Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Mouse models of human cancer as tools in drug development.

Holland EC.

Cancer Cell. 2004 Sep;6(3):197-8.

2.
3.

Using mice to decipher the molecular genetics of brain tumors.

Hesselager G, Holland EC.

Neurosurgery. 2003 Sep;53(3):685-94; discussion 695. Review.

PMID:
12943584
4.

The mighty mouse: genetically engineered mouse models in cancer drug development.

Sharpless NE, Depinho RA.

Nat Rev Drug Discov. 2006 Sep;5(9):741-54. Epub 2006 Aug 18. Review.

PMID:
16915232
5.

Brain tumor animal models: importance and progress.

Holland EC.

Curr Opin Oncol. 2001 May;13(3):143-7. Review.

PMID:
11307055
6.

Only in congenial soil: the microenvironment in brain tumorigenesis.

Rubin JB.

Brain Pathol. 2009 Jan;19(1):144-9. doi: 10.1111/j.1750-3639.2008.00235.x. Review.

PMID:
19076779
7.

Medulloblastoma: mouse models and novel targeted therapies based on the Sonic hedgehog pathway.

Piedimonte LR, Wailes IK, Weiner HL.

Neurosurg Focus. 2005 Nov 15;19(5):E8. Review.

PMID:
16398472
8.

Modeling medulloblastoma with genetically engineered mice.

Fults DW.

Neurosurg Focus. 2005 Nov 15;19(5):E7. Review.

PMID:
16398471
9.

Cancer modeling in the modern era: progress and challenges.

Van Dyke T, Jacks T.

Cell. 2002 Jan 25;108(2):135-44. Review.

10.

Emerging role of new transgenic mouse models in glioma research.

Sonabend AM, Ulasov IV, Lesniak MS.

Expert Rev Anticancer Ther. 2007 Dec;7(12 Suppl):S7-13. doi: 10.1586/14737140.7.12s.S7. Review.

PMID:
18076321
11.

Neural and cancer stem cells in tumor suppressor mouse models of malignant astrocytoma.

Llaguno SA, Chen J, Kwon CH, Parada LF.

Cold Spring Harb Symp Quant Biol. 2008;73:421-6. doi: 10.1101/sqb.2008.73.005. Epub 2008 Nov 6. Review.

PMID:
19022744
12.

Using genetically engineered mouse models of cancer to aid drug development: an industry perspective.

Singh M, Johnson L.

Clin Cancer Res. 2006 Sep 15;12(18):5312-28. Review.

13.

[The role of chemotherapy in pediatric medulloblastoma].

Schuler D.

Magy Onkol. 2010 Jun;54(2):145-52. doi: 10.1556/MOnkol.54.2010.2.9. Review. Hungarian.

14.

Spontaneous and genetically engineered animal models; use in preclinical cancer drug development.

Hansen K, Khanna C.

Eur J Cancer. 2004 Apr;40(6):858-80. Review.

PMID:
15120042
15.

Genetics of medulloblastoma: clues for novel therapies.

Onvani S, Etame AB, Smith CA, Rutka JT.

Expert Rev Neurother. 2010 May;10(5):811-23. doi: 10.1586/ern.10.31. Review.

PMID:
20420498
16.

The utility of genetically altered mouse models for nutrition and cancer chemoprevention research.

Hursting SD, Nunez NP, Patel AC, Perkins SN, Lubet RA, Barrett JC.

Mutat Res. 2005 Aug 25;576(1-2):80-92. Review.

PMID:
15990122
17.

Medulloblastomas: do molecular and biologic markers indicate different prognoses and treatments?

Brandes AA, Paris MK, Basso U.

Expert Rev Anticancer Ther. 2003 Oct;3(5):615-20. Review.

PMID:
14599085
18.

Gliomagenesis: genetic alterations and mouse models.

Holland EC.

Nat Rev Genet. 2001 Feb;2(2):120-9. Review.

PMID:
11253051
19.

Genetic modeling of glioma formation in mice.

Begemann M, Fuller GN, Holland EC.

Brain Pathol. 2002 Jan;12(1):117-32. Review.

PMID:
11770894
20.

Applications of mouse glioma models in preclinical trials.

Hu X, Holland EC.

Mutat Res. 2005 Aug 25;576(1-2):54-65. Review.

PMID:
16011838

Supplemental Content

Support Center